| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.00016 | 1 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 8.6e-05 | 1 |
| mRNA | selumetinib:MK-2206 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 3.1e-05 | 1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 3.3e-05 | 1 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -1e-05 | 1 |
| mRNA | Pyrimethamine | GDSC1000 | pan-cancer | AAC | -6.9e-06 | 1 |